The World Anti-Doping Code 2003 -: Consequences for physicians associated with elite athletes

Publikationstyp:
Zeitschriftenaufsatz
Metadaten:
Autoren
  • H Striegel
  • D Rössner
  • P Simon
  • AM Niess
Autoren-URL
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000228105200013&DestLinkType=FullRecord&DestApp=WOS_CPL
DOI
10.1055/s-2004-830545
Externe Identifier
  • Clarivate Analytics Document Solution ID: 912UK
  • PubMed Identifier: 15776342
ISSN
0172-4622
Ausgabe der Veröffentlichung
3
Zeitschrift
INTERNATIONAL JOURNAL OF SPORTS MEDICINE
Schlüsselwörter
  • doping
  • prevention
  • World Anti-Doping Agency (WADA)
  • World Anti-Doping Code
  • The 2004 Prohibited List
Paginierung
238 - 243
Datum der Veröffentlichung
2005
Status
Published
Titel
The World Anti-Doping Code 2003 -: Consequences for physicians associated with elite athletes
Sub types
  • Article
Ausgabe der Zeitschrift
26

Datenquelle: Web of Science (Lite)

Andere Metadatenquellen:
Autoren
  • H Striegel
  • D Rössner
  • P Simon
  • AM Niess
DOI
10.1055/s-2004-830545
eISSN
1439-3964
ISSN
0172-4622
Ausgabe der Veröffentlichung
3
Zeitschrift
International Journal of Sports Medicine
Sprache
de
Paginierung
238 - 243
Datum der Veröffentlichung
2005
Status
Published
Herausgeber
Georg Thieme Verlag KG
Herausgeber URL
http://dx.doi.org/10.1055/s-2004-830545
Datum der Datenerfassung
2017
Titel
The World Anti-Doping Code 2003 - Consequences for Physicians Associated with Elite Athletes
Ausgabe der Zeitschrift
26

Datenquelle: Crossref

Abstract
The purpose of the World Anti-Doping Code 2003 and the 2004 Prohibited List is to create a universal international standard to fight doping in competitive sports. The result of this is a whole series of changes for doctors with regard to their work with competitive athletes. The revised definition of doping now includes physicians in the group of persons who can fulfil the elements of a doping offence. Moreover, the mere possession of substances appearing on the Prohibited List represents a violation of anti-doping regulations. The 2004 Prohibited List includes several changes to the Olympic Movement List from 2003. Caffeine, for example, was removed from the list. Cannabinoids, on the other hand, are now prohibited in competition for all sports. The same is true for all forms of glucocorticosteroids. Therapeutic use exemptions in an abbreviated process are possible for the administration of glucocorticosteroids by non-systemic routes, as well as inhalative therapy with the beta-2-agonists formoterol, salbutamol, salmeterol, and termbutalin. In other cases, a therapeutic use exemption is possible using a standard application process. Further changes will become effective in the 2005 Prohibited List. In 2005, it is essential that beta-2-agonists are prohibited in and out of competition. HCG and LH are prohibited for all athletes. Dermatological preparations of glucocorticosteroids are no longer prohibited, and intravenous infusions will be a prohibited method in 2005, except as a legitimate acute medical treatment. In cases of violations of anti-doping regulations where it is permissible for the affected person to furnish proof of exoneration, the burden of proof is not higher than that required to prove the violation. The sanctions provided for in the World Anti-Doping Code follow a principle of rules and exceptions which at first glance seems difficult to understand. In the case of doping violations by physicians, the anti-doping code provides--as a general rule--for exclusion from sports associations for at least four years. Since several of the changes are questionable under constitutional aspects, it remains to be seen whether the World Anti-Doping Code 2003 will allow the achievement of a universal standard to combat doping.
Addresses
  • Medical Clinic and Policlinic, Department of Sports Medicine, University of Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany. heiko.striegel@uni-tuebingen.de
Autoren
  • H Striegel
  • D Rössner
  • P Simon
  • AM Niess
DOI
10.1055/s-2004-830545
eISSN
1439-3964
Externe Identifier
  • PubMed Identifier: 15776342
Open access
false
ISSN
0172-4622
Ausgabe der Veröffentlichung
3
Zeitschrift
International journal of sports medicine
Schlüsselwörter
  • Humans
  • Ethanolamines
  • Albuterol
  • Adrenergic beta-Agonists
  • Glucocorticoids
  • Competitive Behavior
  • Physician's Role
  • Doping in Sports
  • Sports
  • Practice Guidelines as Topic
  • Formoterol Fumarate
  • Salmeterol Xinafoate
Sprache
eng
Medium
Print
Paginierung
238 - 243
Datum der Veröffentlichung
2005
Status
Published
Datum der Datenerfassung
2005
Titel
The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
Sub types
  • Journal Article
Ausgabe der Zeitschrift
26

Datenquelle: Europe PubMed Central

Abstract
The purpose of the World Anti-Doping Code 2003 and the 2004 Prohibited List is to create a universal international standard to fight doping in competitive sports. The result of this is a whole series of changes for doctors with regard to their work with competitive athletes. The revised definition of doping now includes physicians in the group of persons who can fulfil the elements of a doping offence. Moreover, the mere possession of substances appearing on the Prohibited List represents a violation of anti-doping regulations. The 2004 Prohibited List includes several changes to the Olympic Movement List from 2003. Caffeine, for example, was removed from the list. Cannabinoids, on the other hand, are now prohibited in competition for all sports. The same is true for all forms of glucocorticosteroids. Therapeutic use exemptions in an abbreviated process are possible for the administration of glucocorticosteroids by non-systemic routes, as well as inhalative therapy with the beta-2-agonists formoterol, salbutamol, salmeterol, and termbutalin. In other cases, a therapeutic use exemption is possible using a standard application process. Further changes will become effective in the 2005 Prohibited List. In 2005, it is essential that beta-2-agonists are prohibited in and out of competition. HCG and LH are prohibited for all athletes. Dermatological preparations of glucocorticosteroids are no longer prohibited, and intravenous infusions will be a prohibited method in 2005, except as a legitimate acute medical treatment. In cases of violations of anti-doping regulations where it is permissible for the affected person to furnish proof of exoneration, the burden of proof is not higher than that required to prove the violation. The sanctions provided for in the World Anti-Doping Code follow a principle of rules and exceptions which at first glance seems difficult to understand. In the case of doping violations by physicians, the anti-doping code provides--as a general rule--for exclusion from sports associations for at least four years. Since several of the changes are questionable under constitutional aspects, it remains to be seen whether the World Anti-Doping Code 2003 will allow the achievement of a universal standard to combat doping.
Autoren
  • H Striegel
  • D Rössner
  • P Simon
  • AM Niess
Autoren-URL
https://www.ncbi.nlm.nih.gov/pubmed/15776342
DOI
10.1055/s-2004-830545
ISSN
0172-4622
Ausgabe der Veröffentlichung
3
Zeitschrift
Int J Sports Med
Schlüsselwörter
  • Adrenergic beta-Agonists
  • Albuterol
  • Competitive Behavior
  • Doping in Sports
  • Ethanolamines
  • Formoterol Fumarate
  • Glucocorticoids
  • Humans
  • Physician's Role
  • Practice Guidelines as Topic
  • Salmeterol Xinafoate
  • Sports
Sprache
eng
Country
Germany
Paginierung
238 - 243
Datum der Veröffentlichung
2005
Status
Published
Datum, an dem der Datensatz öffentlich gemacht wurde
2005
Titel
The World Anti-Doping Code 2003--consequences for physicians associated with elite athletes.
Sub types
  • Journal Article
Ausgabe der Zeitschrift
26

Datenquelle: PubMed

Beziehungen:
Eigentum von

Werkzeuge